(EGPA), based on the clinical features. 1, 3 Generally, AAV may affect almost all the major organs as described in the Birmingham vasculitis activity score (BVAS), which is the most commonly used parameter for assessing the vasculitis activity of AAV.
4,5
The prognostic nutritional index (PNI) is currently reported to indicate a poor prognosis during or after surgery in patients with nutrition-deprived cancers. 6 Moreover, PNI has been considered to reflect immune-related nutritional status. 7 PNI is calculated based on lymphocyte count and serum albumin level in the peripheral circulation. 6 Usually, serum albumin may inversely vary with the inflammatory burden. 8 Moreover, the lymphocyte count may decrease in various autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and primary vasculitides. 9 Particularly, lymphopenia with low numbers of CD4+ T cells can be observed in GPA because of the extensive recruitment of peripheral T cells to the affected tissues. 10 Based on the findings from the previous results, it could be hypothesized that PNI could be associated with the severity and outcome of AAV. However, to our knowledge, no study has clarified the association between PNI at diagnosis and the severity and outcome of AAV. Therefore, we investigated whether PNI at diagnosis is related to disease severity and prognosis of patients with AAV.
| MATERIAL S AND ME THODS

| Patients
The medical records of 160 patients with AAV were reviewed Diseases; and (f) were followed up for at least 12 weeks to assess disease relapse. 16 This study was conducted according to the principles set forth in the Declaration of Helsinki and was approved by the Institutional Review Board of the Hospital (4-2017-0673).
| Assessment of clinical and laboratory data and definition of severe AAV
We obtained age at diagnosis and gender as demographic data.
For the detection of ANCAs, the following methods were used:
P-ANCA and C-ANCA were evaluated by immunofluorescence assay, while MPO-ANCA and PR3-ANCA were measured with an enzyme-linked immunosorbent assay kit for anti-PR3 and anti-MPO 6 We defined severe AAV as BVAS ≥15, which was derived by stratifying the patients into three groups based on high, middle, and low tertiles. The optimal cutoff of BVAS for severe AAV was defined as the lower limit of BVAS in patients within the highest tertile. 
| Statistical analyses
| RE SULTS
| Baseline characteristics of 160 patients with AAV
The baseline characteristics of patients are described in Table 1 .
The mean age at diagnosis was 55.2 years and 48 patients (30.0%)
were male. Eighty-five, 41, and 34 patients were classified as having MPA, GPA, and EGPA, respectively. Among the clinical manifestations, renal manifestations were the most common (59. MPA and EGPA had higher BVAS compared to those with GPA (all P < 0.001), and the BVAS was higher in patients with MPO-vasculitis than in those with PR3-vasculitis and ANCA negative vasculitis (P = 0.005 and P = 0.008, respectively; Figure S1 ).
| Comparison of baseline characteristics between patients with renal manifestation and without
When we divided our patients into those with renal manifestation and without, the proportion of patients with MPA, MPO-ANCA, and cardiovascular manifestations was higher, and the mean BVAS and FFS were also higher in those with renal manifestations. In contrast, EGPA, ANCA negative, and ear-nose-throat manifestations were more commonly found in those without renal manifestations. Regarding laboratory data, the mean ESR was higher, while the mean albumin and PNI was significantly lower in patients with renal manifestations (Table   S1 ).
| Correlation of BVAS with laboratory variables and PNI
In univariable linear regression analysis, BVAS was positively correlated with ESR (r = 0.216, P = 0.006) and CRP (r = 0.169, P = 0.033).
However, BVAS was negatively correlated with lymphocyte count (r = −0.214, P = 0.007) and serum albumin level (r = −0.262, P = 0.001), and was also inversely correlated with PNI (r = −0.307, P < 0.001; Table 2 ). A significant correlation was also found between Table 2 ). Furthermore, PNI was also significantly correlated with the included laboratory variables and the highest correlation was observed with CRP (r = −0.620, P < 0.001), followed by ESR (r = −0.529, P < 0.001) and platelet count (r = −0.384, P < 0.001; Figure 1) . In a subgroup analysis of patients with renal manifestations, serum albumin level and PNI were significantly correlated with spot urine protein/creatinine ratio (r = −0.335 and −0.382, respectively; all P < 0.001).
| The optimal cut-off of PNI for defining severe AAV
We defined patients with severe AAV as those with BVAS ≥15.
The optimal cutoff of PNI for severe AAV was 36.75 (AUROC 0.670, 95% CI 0.592 to 0.743, P < 0.001, Figure S2 ). Figure 2 ).
| Comparison of disease relapse in patients with AAV according to PNI and ANCA serotype
To investigate the association of PNI and ANCA serotype with relapse during the follow-up, Kaplan-Meier survival analysis with the log-rank test was performed. In Kaplan-Meier survival analysis, patients with PNI ≤36.75 and MPO-ANCA positivity (P = 0.002 and P < 0.001) had significantly lower relapse-free rate, but not in those with PR3-ANCA positivity (P = 0.652; Figure 3A -C).
| Factors associated with disease relapse in patients with AAV
We performed Cox proportional hazard analysis to evaluate factors associated with disease relapse in our patients. In univariable analy- 2.066, 95% CI 1.027 to 4.154, P = 0.042) were independent predictors of disease relapse during the follow-up (Table 3 ).
| D ISCUSS I ON
The PNI is an index which was initially proposed by Onodera et al to predict the risk of postoperative complications in patients undergoing gastrointestinal surgeries. 6 However, a growing amount of evidence also suggests that PNI is associated with the prognosis of patients with non-operable malignancies and chronic diseases.
17-19
Furthermore, in a previous study, we have demonstrated that PNI is associated with disease activity in patients with systemic lupus erythematosus, which is a prototypical autoimmune disease. 20 In the present study, to the best of our knowledge, we have first evaluated the clinical significance of PNI in patients with AAV. At disease diagnosis, PNI significantly correlated with BVAS in multivariable linear regression analysis and revealed to be independently associated with disease relapse in Cox proportional hazard analysis even when adjustment with various factors were performed. Our findings altogether suggest that PNI could be a useful index to evaluate disease activity and predicting patient prognosis in AAV.
A negative correlation between PNI and disease activity in AAV which was observed in this study might be attributable to hypoalbuminemia and lymphopenia. In AAV, it is possible that hypoalbuminemia could be related to 3 different medical conditions: malnutrition, proteinuria, and systemic inflammation. First, malnutrition is an item described in BVAS which is defined as a weight F I G U R E 1 Associations between PNI and laboratory variables. In the correlation analysis, PNI was significantly correlated with the included laboratory variables. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; PNI, prognostic nutritional index loss ≥2 kg, 4 and it is known that hypoalbuminemia is related to malnutrition. 21 Second, albumin is a negative acute phase reactant, which could directly be decreased in relation to increased inflammatory burden. [22] [23] [24] [25] Third, persistent proteinuria which could occur in patients with AAV might lead to hypoalbuminemia as a result of albumin loss. 26 It is noteworthy that a significant correlation was observed between serum albumin level, PNI, and spot urine protein/creatinine ratio in a subgroup analysis of patients with renal manifestations. Nevertheless, because patients with renal involvement also had higher disease activity at diagnosis, the causal relationship between disease activity and hypoalbuminemia remains to be further investigated. In addition, a decrease in lymphocyte count can also occur in AAV because of the extensive recruitment of peripheral T cells to the affected tissues. 9,10 Interestingly, our observations revealed that PNI, which includes both serum albumin level and lymphocyte count, exhibited a greater correlation with BVAS compared to either albumin or lymphocyte count alone.
Although improvements have been made in recent years regarding the treatment of AAV, efforts are continuously being made to discover surrogate markers to predict the prognosis of AAV, considering the poor disease course. 27 However, the prognostic factors associated with patient prognosis in AAV still remain inconsistent and controversial, probably owing to the differences in study design and in the high disease heterogeneity. In a previous literature review, age, renal involvement, and treatment were associated with factors affecting patient survival in MPA, while the presence of ANCAs, disease activity, and time to diagnosis were not predictors of disease relapse. 28 On the other hand, MPO-ANCA positivity and higher disease activity were associated with negative prognostic factors for patient survival in a publication by
Flossmann et al 29 Additionally, a recent study by Liang et al suggested that ESR may be a prognostic factor affecting patient survival in patients with AAV with renal injury. 30 In this study, besides MPO-ANCA positivity, PNI of ≤36.75 remained an independent predictor of disease relapse in multivariable Cox proportional hazard analysis. Our findings imply that PNI may be a useful measure to assess patient prognosis in addition to ANCA serotype in patients with AAV. Nevertheless, owing to the retrospective study design and a relatively small number of patients included, additional studies are necessary to validate the findings from our study.
Concerning the association of PNI at diagnosis with disease relapse in AAV, we assume that it might be linked to the inflammatory burden which persists despite both induction and maintenance therapies. The correlation between PNI and laboratory variables that was observed in this study supports this notion. Interestingly, similar findings have also been reported in patients with malignancies, in which patients with lower PNI had a higher rate of cancer recurrence. [31] [32] [33] We hypothesize that a lower PNI at diagnosis could indicate a higher inflammatory burden that may be associated with a later surge of disease activity, which could manifest as disease relapse during the follow-up period. However, the causal relationship between PNI and prognosis of AAV requires further clarification.
Our study has several limitations. First, this study was conducted retrospectively and BVAS and the laboratory data were In conclusion, our study demonstrated that PNI at diagnosis is associated with disease severity and relapse in patients with AAV. These findings suggest that measuring PNI might provide useful information for disease severity estimation and prognostication in AAV.
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